{"id":"https://openalex.org/W1978530024","doi":"https://doi.org/10.1016/s0009-9236(96)90167-8","title":"Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid","display_name":"Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid","alternate_titles":[],"publication_year":1996,"publication_date":"1996-07-01","ids":{"openalex":"https://openalex.org/W1978530024","doi":"https://doi.org/10.1016/s0009-9236(96)90167-8","mag":"1978530024","pmid":"https://pubmed.ncbi.nlm.nih.gov/8689812"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(96)90167-8","doi":"https://doi.org/10.1016/s0009-9236(96)90167-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(96)90167-8","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978530024"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089475081","display_name":"Pertti J. Neuvonen","orcid":"https://orcid.org/0000-0003-3631-9411","observed_orcids":["https://orcid.org/0000-0003-3631-9411"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Pertti J. Neuvonen","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Finland","Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077938841","display_name":"Kirsi-Maija Jalava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kirsi-Maija Jalava","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089475081"],"corresponding_institution_ids":["https://openalex.org/I133731052"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":14.003,"has_fulltext":false,"cited_by_count":242,"citation_normalized_percentile":{"value":0.99727385,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"60","issue":"1","first_page":"54","last_page":"61"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8610000014305115},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.9919999837875366},{"id":"https://openalex.org/keywords/statin-induced-myopathy","display_name":"statin-induced myopathy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/creatine-kinase","display_name":"creatine kinase","score":0.8090000152587891},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8389999866485596},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6919999718666077},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.7960000038146973},{"id":"https://openalex.org/keywords/erythromycin","display_name":"erythromycin","score":0.8180000185966492},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.985022783279419},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7692712545394897},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6788278222084045},{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.6289717555046082},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.5850728750228882},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.5409951210021973},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5232476592063904},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49924659729003906},{"id":"https://openalex.org/C2781064554","wikidata":"https://www.wikidata.org/wiki/Q407883","display_name":"Ketoconazole","level":3,"score":0.4552456736564636},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.422667533159256},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4198293685913086},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.419497013092041},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4134413003921509},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39553290605545044},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3808232843875885},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3166745901107788},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.18507367372512817},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.07872119545936584},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.0},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(96)90167-8","doi":"https://doi.org/10.1016/s0009-9236(96)90167-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(96)90167-8","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:8689812","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8689812","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1484689544","https://openalex.org/W1833888881","https://openalex.org/W1837763605","https://openalex.org/W1972280475","https://openalex.org/W1972432056","https://openalex.org/W1974309728","https://openalex.org/W1979536626","https://openalex.org/W2004576165","https://openalex.org/W2023477614","https://openalex.org/W2037324447","https://openalex.org/W2040869398","https://openalex.org/W2051018092","https://openalex.org/W2052197491","https://openalex.org/W2054040800","https://openalex.org/W2056863521","https://openalex.org/W2067534618","https://openalex.org/W2082314577","https://openalex.org/W2104093795","https://openalex.org/W2122099263","https://openalex.org/W2291391607","https://openalex.org/W2418611981","https://openalex.org/W4246764494","https://openalex.org/W4251032856"],"related_works":["https://openalex.org/W1833059984","https://openalex.org/W2126543805","https://openalex.org/W2087015670","https://openalex.org/W2144159040","https://openalex.org/W2050395450","https://openalex.org/W2089554023","https://openalex.org/W3142627123","https://openalex.org/W2078293971","https://openalex.org/W4247611123","https://openalex.org/W2514430222"],"abstract_inverted_index":{"BACKGROUND:":[0],"Lovastatin":[1,29],"is":[2,30,36],"a":[3,11,37,46,72,83],"cholesterol-lowering":[4],"drug":[5],"that":[6],"can":[7],"cause":[8],"myopathy":[9],"as":[10],"rare":[12],"side":[13],"effect.":[14],"Concomitant":[15],"use":[16,234],"of":[17,25,40,88,92,116,136,171,201,207,215,230,245],"certain":[18],"drugs":[19],"(e.g.,":[20],"cyclosporine)":[21],"increases":[22,198],"the":[23,112,119,122,137,153,175,181,192,212,243],"risk":[24],"skeletal":[26],"muscle":[27],"toxicity.":[28],"metabolized":[31],"by":[32,220,224],"CYP3A4.":[33,231],"Because":[34],"itraconazole":[35,67,110,176,221],"potent":[38],"inhibitor":[39],"CYP3A4,":[41],"we":[42],"wanted":[43],"to":[44,104,147],"study":[45],"possible":[47],"interaction":[48],"between":[49],"these":[50],"drugs.":[51],"METHODS:":[52],"In":[53,159],"this":[54],"double-blind,":[55],"randomized,":[56],"two-phase":[57],"crossover":[58],"study,":[59],"12":[60],"healthy":[61],"volunteers":[62],"received":[63],"either":[64],"200":[65],"mg":[66,86],"or":[68,242],"placebo":[69,182],"orally":[70],"once":[71],"day":[73,78],"for":[74],"4":[75],"days.":[76],"On":[77,108],"4,":[79],"each":[80],"subject":[81,161],"ingested":[82],"single":[84],"40":[85],"dose":[87,244],"lovastatin.":[89],"Plasma":[90],"concentrations":[91,200],"lovastatin,":[93],"lovastatin":[94,117,123,140,172,202,204,216,236],"acid,":[95,141],"itraconazole,":[96],"hydroxyitraconazole,":[97],"and":[98,118,152,203,227,237],"creatine":[99,163,187],"kinase":[100,164,188],"were":[101],"measured":[102],"up":[103],"24":[105,169],"hours.":[106],"RESULTS:":[107],"average,":[109],"increased":[111,143,166,213],"peak":[113],"concentration":[114],"(Cmax)":[115],"area":[120],"under":[121],"concentration-time":[124],"curve":[125],"(AUC)":[126],"more":[127],"than":[128],"twentyfold":[129,155],"(p":[130,156],"<":[131,150,157],"0.001).":[132,158],"The":[133],"mean":[134],"Cmax":[135],"active":[138],"metabolite,":[139],"was":[142,165,189],"13-fold":[144],"(range,":[145],"tenfold":[146,167],"23-fold;":[148],"p":[149],"0.001)":[151],"AUC(0-24)":[154],"one":[160],"plasma":[162,199],"within":[168],"hours":[170],"administration":[173],"during":[174,180],"phase":[177],"but":[178,222],"not":[179,218],"phase.":[183],"No":[184],"increase":[185],"in":[186,191],"observed":[190],"other":[193,228],"subjects.":[194],"CONCLUSIONS:":[195],"Itraconazole":[196],"greatly":[197],"acid.":[205],"Inhibition":[206],"CYP3A4-mediated":[208],"metabolism":[209],"probably":[210],"explains":[211],"toxicity":[214],"caused":[217],"only":[219],"also":[223],"cyclosporine,":[225],"erythromycin,":[226],"inhibitors":[229,250],"Their":[232],"concomitant":[233],"with":[235],"simvastatin":[238],"should":[239,251],"be":[240,252],"avoided,":[241],"3-hydroxy-3-methylglutaryl":[246],"coenzyme":[247],"A":[248],"reductase":[249],"reduced":[253],"accordingly.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978530024","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
